A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin .BETA.1 Expression
2002 ◽
Vol 25
(7)
◽
pp. 857-860
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 19
(8)
◽
pp. 1929-1938
◽
2011 ◽
Vol 404
(1)
◽
pp. 28-33
◽
Keyword(s):
Keyword(s):
2007 ◽
Vol 53
(5)
◽
pp. 1206-1210
◽
1997 ◽
Vol 10
(4)
◽
pp. 154A
◽